Lv1
30 积分 2021-03-22 加入
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
2天前
已完结
Emerging landscape of KRAS inhibitors in cancer treatment
2天前
已完结
A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation
4天前
已完结
Challenges and opportunities in oncology drug development and clinical research in China
6天前
已关闭
Deep generative models design mRNA sequences with enhanced translational capacity and stability
6天前
已完结
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
7天前
已完结
Challenges and opportunities in oncology drug development and clinical research in China
8天前
已完结
Risk of Venous Thromboembolism in Patients With Stage III and IV Non–Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study
3个月前
已完结
Treatment of NSCLC after chemoimmunotherapy - are we making headway?
6个月前
已完结
皖公网安备34019202002308
